Literature DB >> 21510292

Results of surgical treatment of uncontrollable upper gastrointestinal hemorrhage using endoscopy.

Tsy Yeng Choy1, Christian Simoens, Viviane Thill, Freddy Mboti, Shiran Vandaele, Pierre Mendes da Costa.   

Abstract

BACKGROUND/AIMS: Acute hemorrhage of the upper gastrointestinal tract occurs at a rate of 50 to 100 per 100,000 annually in the Western adult population. With the increased use of therapeutic endoscopy, the role of surgery is decreasing; surgical intervention is now only used in cases of failure of endoscopic hemostasis. The goal of this study is to determine whether there are predictive factors associated with high-risk post-operative mortality.
METHODOLOGY: This retrospective study included 30 patients treated from March 1996 to September 2008 at Brugmann Hospital. These patients presented with upper gastrointestinal non-variceal hemorrhage that was treated first endoscopically then surgically for recurrent hemorrhage. Multiple risk factors (variable and fixed) and parameters were evaluated to determine their influence on mortality.
RESULTS: Of 30 patients, 10 (33%) developed recurrent hemorrhage following surgical treatment. A total of 8 (26.6%) deaths occurred of which 4 were related to hemorrhage. Three deaths occurred after the first intervention and 5 occurred after a second intervention. Logistic regression analysis revealed that the total number of blood units transfused and the presence of at least one surgical reintervention both significantly increased mortality rate (p = 0.0426 and p = 0.0068). Other parameters were not significant. However, there is a lack of power due to the small sample size.
CONCLUSION: For recurrent massive upper gastrointestinal hemorrhage following endoscopic treatment and necessitating more than 19 blood transfusions, early surgical intervention is recommended and surgical reintervention should be avoided. If reintervention is necessary, radical surgery is recommended. However, the small number of patients treated over a 12-year period limits the results of this study, and these results may represent simple coincidences.

Entities:  

Mesh:

Year:  2011        PMID: 21510292

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Therapeutic effects and complications of simplified pericardial devascularization for patients with portal hypertension.

Authors:  Hongwei Lu; Sida Liu; Yafei Zhang; Hao Shang; Hong Ji; Yiming Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Diagnosis and management of nonvariceal upper gastrointestinal bleeding.

Authors:  Marc Bardou; Dalila Benhaberou-Brun; Isabelle Le Ray; Alan N Barkun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-10       Impact factor: 46.802

3.  Effect of underdilated transjugular intrahepatic portosystemic shunt on prognosis in patients with prior splenectomy: a propensity score-matched case-control study.

Authors:  Wei Yao; Jia-Cheng Liu; Yong-Juan Wu; Chong-Tu Yang; Shu-Guang Ju; Ying-Liang Wang; Chao-Yang Wang; Song-Jiang Huang; Yao-Wei Bai; Yang Chen; Tong-Qiang Li; Chen Zhou; Bin Xiong
Journal:  Abdom Radiol (NY)       Date:  2022-07-12

4.  Retrospective Study to Compare Selective Decongestive Devascularization and Gastrosplenic Shunt versus Splenectomy with Pericardial Devascularization for the Treatment of Patients with Esophagogastric Varices Due to Cirrhotic Portal Hypertension.

Authors:  Haili Bao; Qikuan He; Ninggao Dai; Ruifan Ye; Qiyu Zhang
Journal:  Med Sci Monit       Date:  2017-06-08

5.  Comparison of simplified and traditional pericardial devascularisation combined with splenectomy for the treatment of portal hypertension.

Authors:  Ya-Fei Zhang; Hong Ji; Hong-Wei Lu; Le Lu; Lei Wang; Jin-Long Wang; Yi-Ming Li
Journal:  World J Clin Cases       Date:  2018-06-16       Impact factor: 1.337

6.  Refractory Nonvariceal Upper Gastrointestinal Bleeding Requiring Surgical Intervention.

Authors:  Edmund Hsu; Singwu D Law
Journal:  Cureus       Date:  2019-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.